Coordinating Multidisciplinary Care - Improving Outcomes after Fragility Fractures.

N Engl J Med

From the Unit of Osteo-Metabolic and Thyroid Diseases, Fondazione Policlinico Campus Bio-Medico, and the Research Unit of Endocrinology and Diabetes, Università Campus Bio-Medico - both in Rome (N.N.); the Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia (P.R.E.); and the Marcus Institute for Aging Research, Hebrew SeniorLife, the Department of Medicine, Beth Israel Deaconess Medical Center, and the Department of Medicine, Harvard Medical School - all in Boston (D.P.K.).

Published: January 2025

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp2409086DOI Listing

Publication Analysis

Top Keywords

coordinating multidisciplinary
4
multidisciplinary care
4
care improving
4
improving outcomes
4
outcomes fragility
4
fragility fractures
4
coordinating
1
care
1
improving
1
outcomes
1

Similar Publications

Same-Day Access for Head and Neck Cancer: Effect on Patient Outcome and Quality-Related Benchmarks.

J Patient Exp

January 2025

Department of Radiation Oncology, Chao Family Comprehensive Cancer Center, University of California-Irvine, School of Medicine, Irvine, CA, USA.

Delays in cancer treatment are detrimental across nearly every disease site in oncology including head and neck cancer. This study aimed to evaluate the impact of same-day access for patients with newly diagnosed head and neck cancer referred for radiation therapy consultation. From March 2021 to March 2023, a total of 50 consecutive patients who completed curative treatment were matched to a control subject who did not use the same-day initiative based on age, gender, histology, performance status, primary tumor site, stage, p16 status, treatment, and smoking history.

View Article and Find Full Text PDF

Art of TIL immunotherapy: SITC's perspective on demystifying a complex treatment.

J Immunother Cancer

January 2025

Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

In a first for solid cancers, cellular immunotherapy has entered standard of care in the treatment of patients with metastatic melanoma. The infusion of autologous tumor-infiltrating T lymphocytes (TIL) is capable of mediating durable tumor regression and is now Food and Drug Administration-approved for patients with disease refractory to immune checkpoint inhibitors. Since the advent of chimeric antigen receptor (CAR) T cells for patients with hematological malignancies, a growing network of centers capable of delivering effector T cell products to patients has developed.

View Article and Find Full Text PDF

Background: To provide recommendations on risk mitigation, diagnosis and treatment of infectious complications associated with the practice of regional anesthesia, acute and chronic pain management.

Methods: Following board approval, in 2020 the American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) commissioned evidence-based guidelines for best practices for infection control. More than 80 research questions were developed and literature searches undertaken by assigned working groups comprising four to five members.

View Article and Find Full Text PDF

The IMmediate Postpartum Access to Cardiac Therapy (IMPACT) procedure is a multidisciplinary, collaborative, highly coordinated clinical service in which a planned delivery and intensive neonatal care are offered for conditions where there is a high likelihood of postnatal instability. This process includes prenatal consultation with the parent(s), involving each service engaged with the delivery, postnatal resuscitation, and procedural care. A Cesarean section delivery is planned in an operating room with immediate access to a multifunctional procedural suite where the neonate can undergo rapid cardiac evaluation and initiation of interventional treatments which can have a positive, life-saving impact.

View Article and Find Full Text PDF

Background: Current guidelines for screening glucose dysregulation (GD) in patients with transfusion-dependent thalassemia (TDT) recommend an annual 2-hour oral glucose tolerance test (OGTT) starting at the age of 10 years.

Objective: Assessment of adherence to OGTT screening in patients with TDT.

Methods: A questionnaire was distributed to 18 Thalassemia Centers in 10 different countries, targeting factors influencing adherence to annual OGTT screening in specialized multidisciplinary pediatric and adult TDT units and identifying strategies to improve adherence to OGTT in TDT patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!